Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César|||0000-0002-3181-4731
  • López-Carrilero, Raquel|||0000-0003-4110-794X
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Catalan, Ana|||0000-0002-0418-7904
  • Aymerich, Claudia|||0000-0003-0040-1608
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Gutiérrez-Zotes, Alfonso|||0000-0002-4858-1487
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • del-Castillo-Serrano, Manuel
  • Vilella, Elisabet|||0000-0002-1887-5919
  • García-Álvarez, Leticia
  • Ochoa, Susana|||0000-0001-6792-1080
  • Correa-Ghisays, Patricia|||0000-0002-1752-7349
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
  • Vicent Sánchez-Ortí, Joan|||0000-0002-8209-6688
  • Pousa Tomàs, Esther|||0000-0003-4423-6739
  • Miret, Salvador|||0000-0002-2275-8272
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael|||0000-0002-0842-898X
  • García-Cabeza, Ignacio|||0000-0002-7542-4321
  • Campos-Rodriguez, Carlos|||0000-0002-6982-1339
  • Crosas Armengol, Josep Maria|||0000-0002-0734-2957
  • Cobo Gomez, Jesus Vicente|||0000-0002-2032-9343
  • Pardina-Torner, Helena|||0000-0002-0720-3412
  • Perona-Garcelán, Salvador|||0000-0002-7771-7857
  • Muñoz-Caracuel, Manuel|||0000-0003-1667-5646
  • Yorca-Ruiz, Ángel|||0000-0002-2701-3755
  • Ortiz García de la Foz, Víctor|||0000-0002-0627-1827
  • Ayesa-Arriola, Rosa|||0000-0003-0570-5352
The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald's omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ 2 = 108.88, p.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César
  • López-Carrilero, Raquel
  • Bobes-Bascarán, Teresa
  • Catalán, Ana
  • Aymerich, Claudia
  • Rodriguez-Jimenez, Roberto
  • Gutiérrez-Zotes, Alfonso
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • Del-Castillo-Serrano, Manuel
  • Vilella, Elisabet
  • García-Álvarez, Leticia
  • Ochoa, Susana
  • Correa-Ghisays, Patricia
  • Balanzá-Martínez, Vicent
  • Sánchez-Ortí, Joan Vicent
  • Pousa, Esther
  • Miret, Salvador
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael
  • García-Cabeza, Ignacio
  • Campos-Rodriguez, Carlos
  • Crosas, Josep Maria
  • Cobo, Jesus
  • Pardina-Torner, Helena
  • Perona-Garcelán, Salvador
  • Muñoz-Caracuel, Manuel
  • Yorca-Ruiz, Ángel
  • Ortiz-García de la Foz, Víctor
  • Ayesa-Arriola, Rosa
Background The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. Methods A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald’s omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Results Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ2 = 108.88, p < .001), with controls performing best, schizophrenia worst, and FEP in between. ROC analyses indicated good discriminative accuracy in distinguishing patients from controls (area under the curve [AUC] = 0.779, sensitivity = 80.0%, specificity = 64.2%); but limited discrimination between schizophrenia and FEP. Age and education, but not sex, significantly affected performance. VRFCAT showed small-to-moderate correlations with cognitive performance, and no significant associations with symptom severity. Conclusions The VRFCAT is a reliable and valid tool for assessing functional capacity in Spanish-speaking individuals with psychotic disorders. Its ecological validity, objectivity, psychometric properties, brief administration time, and ease of use support its potential use in clinical and research settings for evaluating functional recovery and treatment outcomes., This study was supported by the Instituto de Salud Carlos III (ISCIII) through project PI20/00066, co-funded by the European Union. Ana González-Pinto acknowledges the support of the Spanish Ministry of Science, Innovation and Universities, integrated into the National R&D&I Plan and co-funded by the ISCIII–Subdirección General de Evaluación and the European Regional Development Fund (FEDER; grants PI18/01055 and PI21/00713), as well as the CIBERSAM, the Basque Government (grant 2022111054), and the University of the Basque Country (grant IT1631–22). Roberto Rodriguez-Jimenez is partially supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD–7216 (AGES 3–CM)), and CIBERSAM-ISCIII. Ángel Yorca-Ruiz is funded by a predoctoral contract (PFIS FI/00162) from the Carlos III Health Institute. Rosa Ayesa-Arriola was funded by a Miguel Servet contract from the Carlos III Health Institute (CP18/00003) and a Consolidator Grant from the Spanish Ministry of Science and Innovation (CNS2022–136110).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A proxy measure of clinical insight in psychosis: an electronic health records-based validation study

  • López-Díaz, Álvaro
  • López-Morinigo, Javier-David
  • Ortiz-Garcia de la Foz, Victor
  • Marín-Mateo, Helena
  • Ortíz-Jiménez, María Dolores
  • Huarcaya-Victoria, Jeff David
  • Gutiérrez-Talavera, Gerardo
  • González-Blanch, César
  • Crespo-Facorro, Benedicto
  • Cuesta, Manuel Jesús
  • Ayesa-Arriola, Rosa
[Background] Insight assessment in psychosis remains challenging in practice-oriented research., [Aims] To develop and validate a proxy measure for insight based on information from electronic health records (EHR). For that purpose, we used data on the Scale to Assess Unawareness of Mental Disorder (SUMD) and data from EHR notes of patients in an early psychosis intervention programme (Programa de Atención a Fases Iniciales de Psicosis, Santander, Spain)., [Method] Junior and senior clinicians examined 134 clinical notes from 106 patients to explore criterion and content validity between SUMD and a clinician-rated proxy measure, using three SUMD items., [Results] In terms of criterion validity, SUMD scores correlated with the proxy (r = 0.61, P < 0.001), even after adjusting for the following confounders: type of psychotic disorder, clinical remission status and rater experience (r = 0.58, P < 0.001); and the proxy predicted good insight status (odds ratio 20.95, 95% CI 7.32–59.91, P < 0.001). Regarding content validity, the three main SUMD subscores correlated with the proxy (r = 0.55–0.60, P < 0.005). There were no significant differences in age, gender or other clinical variables, i.e. discriminant validity, and the proxy significantly correlated with validated psychometric instruments, i.e. external validity. Intraclass correlation coefficient (i.e. interrater reliability) was 0.88 (95% CI 0.59–1.00, P < 0.05)., [Conclusions] This SUMD-based proxy measure was shown to have good to excellent validity and reliability, which may offer a reliable and efficient alternative for assessing insight in real-world clinical practice, EHR-based research and management. Future studies should explore its applicability across different healthcare contexts and its potential for automation, using natural language-processing techniques., The PAFIP cohort-based projects were carried out at University Hospital Marqués de Valdecilla and Research Institute Valdecilla, and were supported by the Carlos III Health Institute (nos PI14/00639, PI17/00221 and PI20/00066). This work was supported by the Government of Navarra (grant no. 20/21) and by the Carlos III Health Institute (nos ICI21_00089, ICI19_00026 and FEDER Funds) from the Spanish Ministry of Economy and Competitivity (no. 19/1698)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César
  • López-Carrilero, Raquel
  • Bobes-Bascarán, Teresa
  • Catalán, Ana
  • Aymerich, Claudia
  • Rodriguez-Jimenez, Roberto
  • Gutiérrez-Zotes, Alfonso
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • Del-Castillo-Serrano, Manuel
  • Vilella, Elisabet
  • García-Álvarez, Leticia
  • Ochoa, Susana
  • Correa-Ghisays, Patricia
  • Balanzá-Martínez, Vicent
  • Sánchez-Ortí, Joan Vicent
  • Pousa, Esther
  • Miret, Salvador
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael
  • García-Cabeza, Ignacio
  • Campos-Rodriguez, Carlos
  • Crosas, Josep Maria
  • Cobo, Jesus
  • Pardina-Torner, Helena
  • Perona-Garcelán, Salvador
  • Muñoz-Caracuel, Manuel
  • Yorca-Ruiz, Ángel
  • Ortiz-García de la Foz, Víctor
  • Ayesa-Arriola, Rosa
Background The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. Methods A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald’s omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Results Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ2 = 108.88, p < .001), with controls performing best, schizophrenia worst, and FEP in between. ROC analyses indicated good discriminative accuracy in distinguishing patients from controls (area under the curve [AUC] = 0.779, sensitivity = 80.0%, specificity = 64.2%); but limited discrimination between schizophrenia and FEP. Age and education, but not sex, significantly affected performance. VRFCAT showed small-to-moderate correlations with cognitive performance, and no significant associations with symptom severity. Conclusions The VRFCAT is a reliable and valid tool for assessing functional capacity in Spanish-speaking individuals with psychotic disorders. Its ecological validity, objectivity, psychometric properties, brief administration time, and ease of use support its potential use in clinical and research settings for evaluating functional recovery and treatment outcomes., This study was supported by the Instituto de Salud Carlos III (ISCIII) through project PI20/00066, co-funded by the European Union. Ana González-Pinto acknowledges the support of the Spanish Ministry of Science, Innovation and Universities, integrated into the National R&D&I Plan and co-funded by the ISCIII–Subdirección General de Evaluación and the European Regional Development Fund (FEDER; grants PI18/01055 and PI21/00713), as well as the CIBERSAM, the Basque Government (grant 2022111054), and the University of the Basque Country (grant IT1631–22). Roberto Rodriguez-Jimenez is partially supported by the Madrid Regional Government (R&D activities in Biomedicine S2022/BMD–7216 (AGES 3–CM)), and CIBERSAM-ISCIII. Ángel Yorca-Ruiz is funded by a predoctoral contract (PFIS FI/00162) from the Carlos III Health Institute. Rosa Ayesa-Arriola was funded by a Miguel Servet contract from the Carlos III Health Institute (CP18/00003) and a Consolidator Grant from the Spanish Ministry of Science and Innovation (CNS2022–136110).